<DOC>
	<DOCNO>NCT00219076</DOCNO>
	<brief_summary>To evaluate blood pressure lower effect safety aliskiren 150 mg use combination amlodipine 5 mg patient essential hypertension adequately responsive amlodipine 5 mg .</brief_summary>
	<brief_title>A Clinical Study Evaluate Safety Efficacy Combination Aliskiren Amlodipine Hypertensive Non Responders Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Inclusion Criteria Patients essential hypertension Patients eligible able participate study Exclusion Criteria Severe hypertension History evidence secondary form hypertension History Hypertensive encephalopathy cerebrovascular accident . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Hypertension , aliskiren , blood pressure , amlodipine</keyword>
</DOC>